Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Ambea on the public offer for Humana
Mandate

Vinge advises Ambea on the public offer for Humana

June 29, 2026 Capital Markets and Public M&A M&A Banking and Finance Commercial Agreements EU, Competition and Regulatory FDI Public Procurement Corporate Tax Corporate Crime & Compliance

Ambea AB (publ) has made a public offer for all shares in Humana AB. The offer values all shares in Humana at approximately SEK 2,96 billion. The consideration consists of a mix of shares, cash and a CVR (contingent value right).

Vinge’s team primarily consists of Sofie Bjärtun, Linnéa Dolk, Anna Svensson, Lorin Arabi och Samuel Rapp (Capital Markets and Public M&A), Christina Kokko, Samra Tesser, Elsie Nassar och Hedvig Merkel (M&A), Albert Wållgren, Josefine Lanker, Kamyar Najmi och Sara Eirefors (Banking and Finance), Eva Fredrikson, Christoffer Nordin, Nicklas Thorgerzon och Mario Saad (Corporate Commercial), Marcus Glader, Jakob Rosini Jeanrond, Martin Bergqvist, Daniel Wendelsson och Kristoffer Sällfors (Competition and FDI), Maria Schultzberg, Victor Ericsson, Erik Kochbati, Marcus Svärd, Elsa Kalén och Axel Åshuvud (Corporate Tax), Vilma Simonius (Compliance)  samt Alice Vångell (Transaction Support Coordinator).

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

 Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

 HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

 Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026